Amgen

FDA panel backs Pfizer biosim to blockbuster anemia meds from Amgen, Johnson & Johnson
Fierce Pharma
Mon, 05/29/17 - 12:00 pm
FDA
advisory panels
Pfizer
biosimilars
Amgen
Epogen
Procrit
anemia
JNJ
Pfizer's Epogen biosim scores solid backing from FDA staff ahead of panel review
Fierce Pharma
Wed, 05/24/17 - 10:51 am
Pfizer
Epogen
biosimilars
FDA
advisory panels
Amgen
anemia
Amgen's romosozumab red flag on heart safety means a boost for new Radius bone drug
Fierce Pharma
Mon, 05/22/17 - 09:45 am
Amgen
romosozumab
Radius Health
UCB Pharma
Tymlos
osteoporosis
7 Areas to watch from the ASCO abstracts
BioPharma Dive
Fri, 05/19/17 - 11:35 am
ASCO 2017
oncology
Incyte
Merck
Eli Lilly
CAR-T
NewLink Genetics
Amgen
Roche
Kite Pharma
Juno Therapeutics
Amgen inks first money-back guarantee for Repatha
BioPharma Dive
Wed, 05/3/17 - 10:06 am
Amgen
Repatha
insurers
With Amgen hot on its heels, Radius races to get a jump on osteoporosis drug rivalry
Endpoints
Mon, 05/1/17 - 10:57 am
Amgen
Radius Health
osteoporosis
Tymlos
romosozumab
These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016
Motley Fool
Sat, 04/29/17 - 10:12 am
earnings
drug pricing
Biogen
Eli Lilly
AbbVie
Allergan
Merck
Pfizer
Amgen
Three Biotechs Enter…One Biotech Gains
Barron's
Thu, 04/27/17 - 05:55 pm
earnings
Celgene
Alexion
Amgen
Amgen first-quarter profit exceeds Street estimates on lower costs
Yahoo/Reuters
Wed, 04/26/17 - 09:45 pm
Amgen
earnings
U.S. top court grapples over making copycat biologics available sooner
Yahoo/Reuters
Wed, 04/26/17 - 09:39 pm
biosimilars
Neupogen
Amgen
Supreme Court
Analysts offer a lukewarm endorsement to Amgen for PhIII migraine data; Arsanis raises $45.5M Series D; Covance faces restructuring
Endpoints
Wed, 04/26/17 - 11:29 am
migraines
Amgen
Covance
erenumab
Will Low Pricing for Siliq Be Enough to Help Valeant Turn Things Around?
Motley Fool
Tue, 04/25/17 - 11:10 am
Valeant Pharmaceuticals
Siliq
drug pricing
brodalumab
psoriasis
AstraZeneca
Amgen
Earnings Preview: What To Expect From Amgen On Wednesday
Forbes
Tue, 04/25/17 - 11:08 am
earnings
Amgen
With late-stage data in on the CGRP migraine drug erenumab, Novartis and Amgen rework commercialization pact
Endpoints
Tue, 04/25/17 - 11:03 am
Novartis
Amgen
CGRP blockers
migraines
erenumab
Sanofi Genzyme hit with patent lawsuit over new eczema drug
Bizjournals.com
Thu, 04/20/17 - 09:48 am
Sanofi Genzyme
patents
eczema
Dupixent
Immunex
Amgen
3 Big Drugmakers Most Likely to Buy Incyte
Motley Fool
Wed, 04/12/17 - 11:57 am
Incyte
M&A
Gilead Sciences
Amgen
Bristol-Myers Squibb
Amgen Files Marketing Applications to Expand Xgeva's Use to US and EU MM Patients
Yahoo/GuruFocus
Mon, 04/10/17 - 10:02 am
Amgen
Xgeva
Multiple Myeloma
Europe
3 Big Biotech Stocks With Big-Time Catalysts
Motley Fool
Sun, 04/9/17 - 12:36 pm
Regeneron
Praluent
Amgen
biosimilars
Amjevita
Humira
ABP-215
Avastin
ABP-980
Herceptin
Celgene
ozanimod
Earnings Preview: Biotechnology Looks Healthy
Barron's
Sat, 04/8/17 - 12:52 pm
earnings
biotech
Amgen
Celgene
Vertex Pharmaceutials
Biogen
Akorn
[video]What's Next for Amgen's Repatha?
Motley Fool
Tue, 04/4/17 - 07:24 pm
Amgen
Repatha

Pages